Seminars in Hematology
Volume 49, Issue 1 , Pages 4-9 , January 2012

Second Solid Tumors: Screening and Management Guidelines in Long-Term Survivors After Allogeneic Stem Cell Transplantation

  • Gerard Socié

      Affiliations

    • Hematology Transplantation, APHP Hospital Saint Louis and University Paris VII Denis Diderot, Paris, France
    • INSERM U728, Paris, France
    • Corresponding Author InformationAddress correspondence to Gerard Socié, MD, PhD, Hematology/Transplantation, Hospital Saint Louis, 1 Avenue Claude Vellefaux, 75475, Paris CEDEX 10, France
    • ,
  • J. Douglas Rizzo

      Affiliations

    • Center for International Blood and Marrow Transplant Research & Medical College of Wisconsin, Milwaukee, WI

References 

  1. Gooley TA , Chien JW , Pergam SA , et al.  Reduced mortality after allogeneic hematopoietic-cell transplantation . N Engl J Med . 2011;363:2091–2101
  2. Deeg HJ , Socie G . Malignancies after hematopoietic stem cell transplantation: many questions, some answers . Blood . 1998;91: 183344
  3. Deeg HJ , Sanders J , Martin P , et al.  Secondary malignancies after marrow transplantation . Exp Hematol . 1984;12:660–666
  4. Socie G . Secondary malignancies . Curr Opin Hematol . 1996;3:466–470
  5. Majhail NS . Secondary cancers following allogeneic haematopoietic cell transplantation in adults . Br J Haematol . 2011;154:301–310
  6. Bhatia S , Louie AD , Bhatia R , et al.  Solid cancers after bone marrow transplantation . J Clin Oncol . 2001;19:464–471
  7. Bhatia S , Ramsay NK , Steinbuch M , et al.  Malignant neoplasms following bone marrow transplantation . Blood . 1996;87:3633–3639
  8. Curtis RE , Rowlings PA , Deeg HJ , et al.  Solid cancers after bone marrow transplantation . N Engl J Med . 1997;336:897–904
  9. Kolb HJ , Socie G , Duell T , et al.  Malignant neoplasms in long-term survivors of bone marrow transplantation (Late Effects Working Party of the European Cooperative Group for Blood and Marrow Transplantation and the European Late Effect Project Group) . Ann Intern Med . 1999;131:738–744
  10. Rizzo JD , Curtis RE , Socie G , et al.  Solid cancers after allogeneic hematopoietic cell transplantation . Blood . 2009;113:1175–1183
  11. Baker KS , DeFor TE , Burns LJ , Ramsay NK , Neglia JP , Robison LL . New malignancies after blood or marrow stem-cell transplantation in children and adults: incidence and risk factors . J Clin Oncol . 2003;21:1352–1358
  12. Shimada K , Yokozawa T , Atsuta Y , et al.  Solid tumors after hematopoietic stem cell transplantation in Japan: incidence, risk factors and prognosis . Bone Marrow Transplant . 2005;36:115–121
  13. Gallagher G , Forrest DL . Second solid cancers after allogeneic hematopoietic stem cell transplantation . Cancer . 2007;109:84–92
  14. Socie G , Stone JV , Wingard JR , et al.  Long-term survival and late deaths after allogeneic bone marrow transplantation (Late Effects Working Committee of the International Bone Marrow Transplant Registry) . N Engl J Med . 1999;341:14–21
  15. Wingard JR , Majhail NS , Brazauskas R , et al.  Long-term survival and late deaths after allogeneic hematopoietic cell transplantation . J Clin Oncol . 2011;29:2230–2239
  16. Martin PJ , Counts GW , Appelbaum FR , et al.  Life expectancy in patients surviving more than 5 years after hematopoietic cell transplantation . J Clin Oncol . 2011;28:1011–1016
  17. Duell T , van Lint MT , Ljungman P , et al.  Health and functional status of long-term survivors of bone marrow transplantation (EBMT Working Party on Late Effects and EULEP Study Group on Late Effects. European Group for Blood and Marrow Transplantation). Ann Intern Med . 1997;126:184–192
  18. Bhatia S , Francisco L , Carter A , et al.  Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study . Blood . 2007;110:3784–3792
  19. Allan JM , Travis LB . Mechanisms of therapy-related carcinogenesis . Nat Rev Cancer . 2005;5:943–955
  20. Masserot C , Peffault de Latour R , Rocha V , et al.  Head and neck squamous cell carcinoma in 13 patients with Fanconi anemia after hematopoietic stem cell transplantation . Cancer . 2008;113:3315–3322
  21. Rosenberg PS , Socie G , Alter BP , Gluckman E . Risk of head and neck squamous cell cancer and death in patients with Fanconi anemia who did and did not receive transplants . Blood . 2005;105:67–73
  22. Millen FJ , Rainey MG , Hows JM , Burton PA , Irvine GH , Swirsky D . Oral squamous cell carcinoma after allogeneic bone marrow transplantation for Fanconi anaemia . Br J Haematol . 1997;99:410–414
  23. Fenske TS , McMahon C , Edwin D , et al.  Identification of candidate alkylator-induced cancer susceptibility genes by whole genome scanning in mice . Cancer Res . 2006;66:5029–5038
  24. Wynn RF , Cross MA , Hatton C , et al.  Accelerated telomere shortening in young recipients of allogeneic bone-marrow transplants . Lancet . 1998;351:178–181
  25. Chakraborty S , Sun CL , Francisco L , et al.  Accelerated telomere shortening precedes development of therapy-related myelodysplasia or acute myelogenous leukemia after autologous transplantation for lymphoma . J Clin Oncol . 2009;27:791–798
  26. Faber P , Fisch P , Waterhouse M , et al.  Frequent genomic alterations in epithelium measured by microsatellite instability following allogeneic hematopoietic cell transplantation in humans . Blood . 2006;107:3389–3396
  27. Khan FM , Sy S , Louie P , et al.  Genomic instability after allogeneic hematopoietic cell transplantation is frequent in oral mucosa, particularly in patients with a history of chronic graft-versus-host disease, and rare in nasal mucosa . Blood . 2011;116:1803–1806
  28. Themeli M , Petrikkos L , Waterhouse M , et al.  Alloreactive microenvironment after human hematopoietic cell transplantation induces genomic alterations in epithelium through an ROS-mediated mechanism: in vivo and in vitro study and implications to secondary neoplasia . Leukemia . 2011;24:536–543
  29. Friedman DL , Leisenring W , Schwartz JL , Deeg HJ . Second malignant neoplasms following hematopoietic stem cell transplantation . Int J Hematol . 2004;79:229–234
  30. Socie G , Scieux C , Gluckman E , et al.  Squamous cell carcinomas after allogeneic bone marrow transplantation for aplastic anemia: further evidence of a multistep process . Transplantation . 1998;66:667–670
  31. Witherspoon RP , Fisher LD , Schoch G , et al.  Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia . N Engl J Med . 1989;321:784–789
  32. Socie G , Henry-Amar M , Cosset JM , Devergie A , Girinsky T , Gluckman E . Increased incidence of solid malignant tumors after bone marrow transplantation for severe aplastic anemia . Blood . 1991;78:277–279
  33. Deeg HJ , Socie G , Schoch G , et al.  Malignancies after marrow transplantation for aplastic anemia and fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients . Blood . 1996;87:386–392
  34. Socie G , Curtis RE , Deeg HJ , et al.  New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia . J Clin Oncol . 2000;18:348–357
  35. Curtis RE , Metayer C , Rizzo JD , et al.  Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study . Blood . 2005;105:3802–3811
  36. Majhail NS , Brazauskas R , Rizzo JD , et al.  Secondary solid cancers after allogeneic hematopoietic cell transplantation using busulfan-cyclophosphamide conditioning . Blood . 2011;117:316–322
  37. Leisenring W , Friedman DL , Flowers ME , Schwartz JL , Deeg HJ . Nonmelanoma skin and mucosal cancers after hematopoietic cell transplantation . J Clin Oncol . 2006;24:1119–1126
  38. Schwartz JL , Kopecky KJ , Mathes RW , Leisenring WM , Friedman DL , Deeg HJ . Basal cell skin cancer after total-body irradiation and hematopoietic cell transplantation . Radiat Res . 2009;171:155–163
  39. Peffault de Latour R , Levy V , Asselah T , et al.  Long-term outcome of hepatitis C infection after bone marrow transplantation . Blood . 2004;103:1618–1624
  40. Cohen A , Rovelli A , Merlo DF , et al.  Risk for secondary thyroid carcinoma after hematopoietic stem-cell transplantation: an EBMT Late Effects Working Party Study . J Clin Oncol . 2007;25:2449–2454
  41. Friedman DL , Rovo A , Leisenring W , et al.  Increased risk of breast cancer among survivors of allogeneic hematopoietic cell transplantation: a report from the FHCRC and the EBMT-Late Effect Working Party . Blood . 2008;111:939–944
  42. Rizzo JD , Wingard JR , Tichelli A , et al.  Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, Center for International Blood and Marrow Transplant Research, and the American Society for Blood and Marrow Transplantation (EBMT/CIBMTR/ASBMT) . Bone Marrow Transplant . 2006;37:249–261

 Disclosure: none

PII: S0037-1963(11)00107-7

doi: 10.1053/j.seminhematol.2011.10.013

Seminars in Hematology
Volume 49, Issue 1 , Pages 4-9 , January 2012

Article Tools